Ruta Navakauskiene Selected Research

N1- (2- aminophenyl)- N8- phenyloctanediamide

12/2012	Histone deacetylase inhibitor BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells.
1/2012	Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells.
12/2006	Retinoic acid and histone deacetylase inhibitor BML-210 inhibit proliferation of human cervical cancer HeLa cells.
11/2006	The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruta Navakauskiene Research Topics

Disease

13	Leukemia 11/2018 - 12/2002
8	Neoplasms (Cancer) 01/2019 - 12/2006
5	Acute Promyelocytic Leukemia 01/2019 - 12/2004
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2014 - 01/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2012 - 12/2006
1	Mental Disorders (Mental Disorder) 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Breast Ductal Carcinoma 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2018
1	Carcinogenesis 07/2014
1	Muscular Dystrophies (Muscular Dystrophy) 12/2012
1	Carcinoma (Carcinomatosis) 12/2006
1	Lymphoma (Lymphomas) 12/2006

Drug/Important Bio-Agent (IBA)

9	Histone Deacetylase InhibitorsIBA 09/2014 - 11/2006
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2014 - 12/2002
4	N1- (2- aminophenyl)- N8- phenyloctanediamideIBA 12/2012 - 11/2006
3	Histones (Histone)IBA 07/2014 - 12/2006
3	Proteins (Proteins, Gene)FDA Link 12/2012 - 12/2002
3	Butyrates (Butyrate)IBA 01/2012 - 12/2006
3	Transcription Factors (Transcription Factor)IBA 01/2011 - 12/2004
2	Pharmaceutical PreparationsIBA 01/2021 - 09/2014
2	BIX 01294IBA 11/2018 - 07/2014
2	belinostatIBA 07/2015 - 09/2014
2	Histone Deacetylases (Histone Deacetylase)IBA 09/2014 - 08/2009
2	pyrimidin-2-one beta-ribofuranosideIBA 12/2012 - 01/2012
2	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2011 - 12/2006
2	romidepsin (FK228)FDA Link 01/2011 - 12/2006
2	SodiumIBA 01/2011 - 12/2006
2	NF-kappa B (NF-kB)IBA 12/2006 - 12/2004
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	Amyloid beta-PeptidesIBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 11/2018
1	Lysine (L-Lysine)FDA Link 07/2014
1	MethyltransferasesIBA 07/2014
1	Histone MethyltransferasesIBA 07/2014
1	NucleosidesIBA 12/2012
1	1,2- diarachidonoyl- glycero- 3- phosphocholineIBA 12/2012
1	RG108IBA 12/2012
1	CytidineIBA 01/2012
1	Cadherins (E-Cadherin)IBA 01/2012
1	ChromatinIBA 01/2011
1	Growth InhibitorsIBA 12/2006
1	DepsipeptidesIBA 12/2006
1	Histone Deacetylase 1IBA 12/2006
1	Etoposide (VP 16)FDA LinkGeneric 12/2004
1	phorbolIBA 12/2004
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 12/2004
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 12/2004
1	CaspasesIBA 12/2004
1	Tyrosine (L-Tyrosine)FDA Link 04/2004
1	Protein Isoforms (Isoforms)IBA 12/2002
1	dystrobrevinIBA 12/2002

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2012